The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

P. Fouqueray, V. Pirags, S.E. Inzucchi, C.J. Bailey, G. Schernthaner, M. Diamant, H.E. Lebovitz

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)565-568
JournalDiabetes Care
Volume36
Issue number3
DOIs
Publication statusPublished - 2013

Cite this

Fouqueray, P., Pirags, V., Inzucchi, S. E., Bailey, C. J., Schernthaner, G., Diamant, M., & Lebovitz, H. E. (2013). The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy. Diabetes Care, 36(3), 565-568. https://doi.org/10.2337/dc12-0453